Pioneers in Neuroscience

Biogen Idec Limited

Innovation House
70 Norden Road
Berkshire SL6 4AY
United Kingdom

Phone: +44 1628 501 000
Fax: +44 1628 501 010

About Biogen

At Biogen, our mission is clear: we are pioneers in neuroscience.


The National Institute for Health and Care Excellence (NICE) has recommended funding for Spinraza (nusinersen) on the National Health Service for the treatment of infants, children and adults with 5q spinal muscular atrophy (SMA), including pre-symptomatic and SMA types I, II and III. 

Working at Biogen United Kingdom

We work together to bring life-changing therapies to patients every day. Start here to find the fulfilling career opportunity that’s right for you.

Transparency reporting

Biogen is committed to meeting all global transparency requirements. As is our obligation, we record all transfers of value to healthcare professionals and organisations and report in accordance with the applicable local codes and laws.

Learn more about Biogen on our global site


CO-GBR-0002    Date of preparation: October 2018